D.E. Shaw & Co’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Sell |
390,648
-4,603
| -1% | -$15.5K | ﹤0.01% | 2106 |
|
|
2025
Q1 | $1.53M | Sell |
395,251
-117,079
| -23% | -$452K | ﹤0.01% | 1988 |
|
|
2024
Q4 | $3.16M | Sell |
512,330
-70,528
| -12% | -$435K | ﹤0.01% | 1554 |
|
|
2024
Q3 | $3.14M | Buy |
582,858
+47,074
| +9% | +$253K | ﹤0.01% | 1559 |
|
|
2024
Q2 | $1.79M | Buy |
535,784
+89,594
| +20% | +$300K | ﹤0.01% | 1865 |
|
|
2024
Q1 | $1.8M | Buy |
446,190
+155,562
| +54% | +$627K | ﹤0.01% | 1839 |
|
|
2023
Q4 | $770K | Buy |
290,628
+278,888
| +2,376% | +$739K | ﹤0.01% | 2194 |
|
|
2023
Q3 | $27.7K | Sell |
11,740
-123,540
| -91% | -$292K | ﹤0.01% | 2771 |
|
|
2023
Q2 | $852K | Buy |
135,280
+23,982
| +22% | +$151K | ﹤0.01% | 2145 |
|
|
2023
Q1 | $642K | Buy |
+111,298
| New | +$642K | ﹤0.01% | 2409 |
|